BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32579898)

  • 1. Regulation of Cas9 by viral proteins Tat and Rev for HIV-1 inactivation.
    Vergara-Mendoza M; Gomez-Quiroz LE; Miranda-Labra RU; Fuentes-Romero LL; Romero-Rodríguez DP; González-Ruiz J; Hernández-Rizo S; Viveros-Rogel M
    Antiviral Res; 2020 Aug; 180():104856. PubMed ID: 32579898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9 Ablation of Integrated HIV-1 Accumulates Proviral DNA Circles with Reformed Long Terminal Repeats.
    Lai M; Maori E; Quaranta P; Matteoli G; Maggi F; Sgarbanti M; Crucitta S; Pacini S; Turriziani O; Antonelli G; Heeney JL; Freer G; Pistello M
    J Virol; 2021 Nov; 95(23):e0135821. PubMed ID: 34549986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplexed
    Ophinni Y; Miki S; Hayashi Y; Kameoka M
    Viruses; 2020 Oct; 12(11):. PubMed ID: 33126728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination.
    Herskovitz J; Hasan M; Patel M; Blomberg WR; Cohen JD; Machhi J; Shahjin F; Mosley RL; McMillan J; Kevadiya BD; Gendelman HE
    EBioMedicine; 2021 Nov; 73():103678. PubMed ID: 34774454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplexed Simian Immunodeficiency Virus-Specific Paired RNA-Guided Cas9 Nickases Inactivate Proviral DNA.
    Smith LM; Ladner JT; Hodara VL; Parodi LM; Harris RA; Callery JE; Lai Z; Zou Y; Raveedran M; Rogers J; Giavedoni LD
    J Virol; 2021 Nov; 95(23):e0088221. PubMed ID: 34549979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures.
    Ophinni Y; Inoue M; Kotaki T; Kameoka M
    Sci Rep; 2018 May; 8(1):7784. PubMed ID: 29773895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape.
    Darcis G; Binda CS; Klaver B; Herrera-Carrillo E; Berkhout B; Das AT
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30871200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape.
    Lebbink RJ; de Jong DC; Wolters F; Kruse EM; van Ham PM; Wiertz EJ; Nijhuis M
    Sci Rep; 2017 Feb; 7():41968. PubMed ID: 28176813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.
    Likhoshvai VA; Khlebodarova TM; Bazhan SI; Gainova IA; Chereshnev VA; Bocharov GA
    BMC Genomics; 2014; 15 Suppl 12(Suppl 12):S1. PubMed ID: 25564443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9 Inhibits Multiple Steps of HIV-1 Infection.
    Yin L; Hu S; Mei S; Sun H; Xu F; Li J; Zhu W; Liu X; Zhao F; Zhang D; Cen S; Liang C; Guo F
    Hum Gene Ther; 2018 Nov; 29(11):1264-1276. PubMed ID: 29644868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the mechanisms underlying the inactivation of HIV-1 proviruses by CRISPR/Cas.
    Mefferd AL; Bogerd HP; Irwan ID; Cullen BR
    Virology; 2018 Jul; 520():116-126. PubMed ID: 29857168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Combinatorial CRISPR-Cas9 Attack on HIV-1 DNA Extinguishes All Infectious Provirus in Infected T Cell Cultures.
    Wang G; Zhao N; Berkhout B; Das AT
    Cell Rep; 2016 Dec; 17(11):2819-2826. PubMed ID: 27974196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A CRISPR/Cas9 guidance RNA screen platform for HIV provirus disruption and HIV/AIDS gene therapy in astrocytes.
    Huang Z; Nair M
    Sci Rep; 2017 Jul; 7(1):5955. PubMed ID: 28729655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Efficiency for Biallelic Mutations of the
    Lin D; Scheller SH; Robinson MM; Izadpanah R; Alt EU; Braun SE
    CRISPR J; 2021 Feb; 4(1):92-103. PubMed ID: 33616448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic gRNA/Cas9 Ribonucleoprotein Inhibits HIV Reactivation and Replication.
    Khanal S; Cao D; Zhang J; Zhang Y; Schank M; Dang X; Nguyen LNT; Wu XY; Jiang Y; Ning S; Zhao J; Wang L; Gazzar ME; Moorman JP; Yao ZQ
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-CAS Replacing Antiviral Drugs against HIV: An Update.
    Hashmat R; Yousaf MZ; Rahman Z; Anjum KM; Yaqoob A; Imran M
    Crit Rev Eukaryot Gene Expr; 2020; 30(1):77-83. PubMed ID: 32421986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatorial CRISPR-Cas9 and RNA Interference Attack on HIV-1 DNA and RNA Can Lead to Cross-Resistance.
    Zhao N; Wang G; Das AT; Berkhout B
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional screening of guide RNAs targeting the regulatory and structural HIV-1 viral genome for a cure of AIDS.
    Yin C; Zhang T; Li F; Yang F; Putatunda R; Young WB; Khalili K; Hu W; Zhang Y
    AIDS; 2016 May; 30(8):1163-74. PubMed ID: 26990633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of transcription inhibition and generation of suppressive viral non-coding RNAs.
    Pinto DO; Scott TA; DeMarino C; Pleet ML; Vo TT; Saifuddin M; Kovalskyy D; Erickson J; Cowen M; Barclay RA; Zeng C; Weinberg MS; Kashanchi F
    Retrovirology; 2019 Apr; 16(1):13. PubMed ID: 31036006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.